Concentra Group Holdings Parent, Inc. announced a leadership succession effective November 1, 2026. Matthew DiCanio will transition from President and Chief Financial Officer to President and Chief Executive Officer. Keith Newton will step down as CEO to become Executive Chairman of the Board. Tanner Newton has been appointed Executive Vice President and Chief Financial Officer, succeeding his father, Keith Newton. Tanner Newton previously served as Senior Vice President, Strategy & Finance since January 2025. The company operates in the occupational medicine and workforce health services industry.

Concentra Group Holdings Parent, Inc. reported second quarter 2026 financial results and announced a leadership transition effective November 1, 2026. CEO Keith Newton will step down to become Executive Chairman, while President and CFO Matt DiCanio succeeds him as President and CEO; Board Chair Robert Ortenzio also resigns from the chair role. The company raised its full-year 2026 guidance for revenue ($2.325 billion–$2.375 billion), Adjusted EBITDA ($485 million–$495 million), and Free Cash Flow ($220 million–$240 million). Q2 revenue grew 10.0% to $606.0 million, with net income attributable increasing 46.5% to $65.3 million and Adjusted EBITDA rising 22.5% to $140.9 million. The Board declared a quarterly cash dividend of $0.0625 per share, payable August 28, 2026, to record holders on August 20, 2026. Concentra operates in the occupational health services industry, providing workplace medical care through centers and onsite clinics.

On July 6, 2026, Concentra Health Services, Inc., a subsidiary of Concentra Group Holdings Parent, Inc., entered into a consulting agreement with Dr. John R. Anderson following his announced retirement as Executive Vice President and Chief Medical Officer on December 31, 2026. Effective January 1, 2027, through December 31, 2027, Dr. Anderson will serve as an independent contractor providing up to 10 hours of consulting per week at a rate of $216.00 per hour. The agreement allows for the continued vesting of his restricted stock awards, with an additional 25% of unvested stock vesting upon completion of the term. The company operates in the healthcare industry, providing occupational health and urgent care services.